Ultralife Corporation
ULBI
$5.52
$0.1753.28%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 9.95% | 17.37% | 26.44% | 20.33% | 25.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.95% | 17.37% | 26.44% | 20.33% | 25.70% |
| Cost of Revenue | 6.74% | 12.25% | 21.17% | 16.60% | 23.24% |
| Gross Profit | 20.17% | 34.70% | 44.70% | 33.33% | 34.23% |
| SG&A Expenses | 2.31% | 3.77% | 1.33% | 0.02% | 9.53% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.97% | 10.35% | 16.71% | 13.25% | 19.80% |
| Operating Income | 105.03% | 314.33% | 2,902.67% | 7,244.96% | 817.70% |
| Income Before Tax | 94.15% | 247.59% | 2,727.89% | 2,144.17% | 500.28% |
| Income Tax Expenses | 23.48% | 127.18% | 1,439.90% | 698.47% | 501.31% |
| Earnings from Continuing Operations | 120.63% | 294.74% | 3,639.12% | 6,071.67% | 499.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -488.89% | 186.67% | 1,066.67% | 3,000.00% | 400.00% |
| Net Income | 119.29% | 297.59% | 3,613.13% | 6,147.90% | 499.61% |
| EBIT | 105.03% | 314.33% | 2,902.67% | 7,244.96% | 817.70% |
| EBITDA | 62.88% | 137.50% | 267.82% | 191.76% | 186.68% |
| EPS Basic | 115.70% | 291.07% | 3,583.15% | 6,089.19% | 497.34% |
| Normalized Basic EPS | 66.64% | 201.54% | 2,381.73% | 1,799.42% | 698.63% |
| EPS Diluted | 119.63% | 300.60% | 2,509.92% | 2,953.29% | 474.24% |
| Normalized Diluted EPS | 65.03% | 198.60% | 2,372.59% | 1,794.80% | 697.80% |
| Average Basic Shares Outstanding | 1.98% | 1.54% | 0.90% | 0.55% | 0.31% |
| Average Diluted Shares Outstanding | 3.06% | 2.44% | 1.38% | 0.84% | 0.38% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
